Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients Meeting Abstract
| Authors: | Rudin, C. M.; Pandha, H. S.; Gupta, S.; Zibelman, M. R.; Akerley, W.; Day, D.; Hill, A. G.; Sanborn, R. E.; O'Day, S. J.; Clay, T. D.; Wright, G. M.; Jennens, R.; Gerber, D. E.; Rosenberg, J. E.; Ralph, C.; Campbell, D. C.; Curti, B. D.; Schmidt, E. V.; Grose, M.; Shafren, D. |
| Abstract Title: | Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy424.050 |
| Language: | English |
| ACCESSION: | WOS:000459277304400 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy424.050 |
| Notes: | Meeting Abstract: LBA40 -- Appears on page viii732 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
